Form 4: InMed Pharmaceuticals Executive Exercises Stock Options
SEC Form 4 Filing
Alexandra Diane Janet Mancini, Sr VP of Clinical and Regulatory Affairs at InMed Pharmaceuticals, exercised employee stock options on May 27, 2024.
Summary
- Alexandra Diane Janet Mancini, a Senior VP at InMed Pharmaceuticals, exercised employee stock options.
- The transaction occurred on May 27, 2024.
- Mancini exercised options for 485 common shares at an exercise price of $263.18.
- Following the transaction, Mancini directly owns 52,000 derivative securities.
- The options were originally granted on May 27, 2019, and expired on May 27, 2024.
Sentiment
Score: 5
Explanation: Neutral sentiment as it's a standard regulatory filing regarding stock option exercise.
Industry Context
This is a routine disclosure related to executive compensation and stock option exercises, common in publicly traded companies.
Key Dates
| Date | Description |
|---|---|
| 05/27/2019 | Original grant date of the employee stock options |
| 05/27/2024 | Date of transaction: Mancini exercised stock options and expiration date of the options |
| 05/28/2024 | Date of signature on the Form 4 filing |
Keywords
stock options, Form 4, derivative securities, beneficial ownership, InMed Pharmaceuticals, Mancini, executive compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.